Combined analysis of MAF value, pathogenicity analysis, and family co-segregation ruled out the possibility of other keratoconus genes or novel variants, as whole exome sequencing was performed on these KC patients with VSX1 sequence variation sites. This evidence concerns the gene VSX1 and keratoconus.